Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Identify which cards offer the highest cash back. This guide will help you maximize your rewards on everyday spending.
26,208 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Salesforce unveiled a $50 billion buyback and a new AI metric, but traders remain wary that AI disruption could erode...
As autonomous driving heats up, two stocks stand out as potential multibagger candidates by 2030. This article breaks...
Two affordable small-cap stocks under $15 are drawing retail investors' attention as steady packaged foods demand and...
Warren Buffett has long championed simple, cost-effective investing. This Warren Buffett-approved investment, a low-c...
Losing a spouse is hard, and navigating survivor benefits can feel overwhelming. This guide breaks down how survivor ...
Costco’s iconic $1.50 hot dog combo endures as inflation bites elsewhere. Meanwhile, retirees face a long-running tax...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
Geopolitical tensions push on-chain activity higher, with stablecoin liquidity rising as crypto assets resist broader...
A real-world case shows how the disabled adult child benefit can unlock substantial monthly income when a parent clai...
SpaceX aims for a record public debut valued at $1.75 trillion. History warns mega-IPOs can swing wildly in year one,...
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...